Items where Author is "Ghaedrahmati, F."

Article

(2025) Exosomes and non-coding RNAs: Exploring their roles in human myocardial dysfunction. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. p. 117853. ISSN 1950-6007 (Electronic) 0753-3322 (Linking)

(2025) Exploring the Gut Microbiota as a Promising Target for Breast Cancer Treatment. Current Molecular Medicine. p. 18. ISSN 1566-5240

(2025) Insights into the Biological Properties of Prostate Cancer Stem Cells: Implications for Cancer Progression and Therapy. Current stem cell research & therapy. pp. 166-182. ISSN 2212-3946 (Electronic) 1574-888X (Linking)

(2025) LncRNA-DANCR: A Key Player in Colorectal Cancer Development and Progression. Current Molecular Medicine. ISSN 1875-5666 (Electronic) 1566-5240 (Linking)

(2024) Diversity in the Clinical Course and Outcome of COVID-19 in Patients with Different Inborn Errors of Immunity can be Associated with the Type of Error. Advanced Biomedical Research. p. 11. ISSN 2277-9175

(2024) Emerging biologic and clinical implications of miR-182-5p in gynecologic cancers. Clinical & Translational Oncology. p. 16. ISSN 1699-048X

(2024) Exploring the Dual Role of MALAT1 in Thyroid Tumorigenesis: Oncogenic or Tumor Suppressor? Current Molecular Medicine. p. 8. ISSN 1566-5240

(2024) The Mechanisms of Long Non-coding RNA-XIST in Ischemic Stroke: Insights into Functional Roles and Therapeutic Potential. Molecular Neurobiology. pp. 2745-2753. ISSN 1559-1182 (Electronic) 0893-7648 (Linking)

(2024) More balance toward activating receptors and cytotoxic activity of NK cells ex vivo differentiated from human umbilical cord blood-derived CD34+stem cells in comparison with peripheral blood NK cells. Heliyon. p. 16.

(2024) Strong capacity of differentiated PD-L1 CAR-modified UCB-CD34+ cells and PD-L1 CAR-modified UCB-CD34+-derived NK cells in killing target cells and restoration of the anti-tumor function of PD-1-high exhausted T Cells. Stem Cell Research & Therapy. p. 17.

(2023) Circular RNAs-mediated angiogenesis in human cancers. Clinical & Translational Oncology. pp. 3101-3121. ISSN 1699-048X

(2023) Endometrial Cancer Stem Cells Related Signaling Pathways. Current Cancer Therapy Reviews. pp. 284-291. ISSN 1573-3947

(2023) Functional Roles of lncRNAs in Recurrent Pregnancy Loss: A Review Study. International Journal of Fertility & Sterility. pp. 218-225. ISSN 2008-076X

(2023) Long non-coding RNAs involved in retinoblastoma. Journal of Cancer Research and Clinical Oncology. pp. 401-421. ISSN 1432-1335 (Electronic) 0171-5216 (Linking)

(2023) Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells. Clinical & Translational Oncology. pp. 2015-2042. ISSN 1699-048X

(2023) Signaling pathways governing glioma cancer stem cells behavior. Cellular Signalling. p. 110493. ISSN 1873-3913 (Electronic) 0898-6568 (Linking)

(2023) Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors. Cancer communications (London, England). pp. 177-213. ISSN 2523-3548 (Electronic) 2523-3548 (Linking)

(2023) Unveiling Mesenchymal Stem Cells' Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications. Cells. p. 34.

(2023) The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma. Bmc Nephrology. p. 10.

(2023) The role of LncRNA MCM3AP-AS1 in human cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. pp. 33-47. ISSN 1699-3055 (Electronic) 1699-048X (Linking)

(2023) An updated review of contribution of long noncoding RNA-NEAT1 to the progression of human cancers. Pathology Research and Practice. p. 17. ISSN 0344-0338

(2022) Emerging roles for lncRNA-NEAT1 in colorectal cancer. Cancer Cell International. p. 209. ISSN 1475-2867 (Print) 1475-2867 (Electronic) 1475-2867 (Linking)

(2022) Emerging roles for lncRNA-NEAT1 in colorectal cancer. CANCER CELL INTERNATIONAL. ISSN 1475-2867 J9 - CANCER CELL INT

(2022) Emerging roles of JMJD3 in cancer. CLINICAL & TRANSLATIONAL ONCOLOGY. pp. 1238-1249. ISSN 1699-048X 1699-3055 J9 - CLIN TRANSL ONCOL

(2022) Emerging roles of JMJD3 in cancer (vol 24, pg 1238, 2022). Clinical & Translational Oncology. p. 2044. ISSN 1699-048X

(2022) Functional roles of lncRNA-TUG1 in hepatocellular carcinoma. Life Sciences. p. 10. ISSN 0024-3205

(2022) An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy. FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224 J9 - FRONT IMMUNOL

(2022) The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer. Cancer Cell International. p. 8.

(2022) The role of LncRNA MCM3AP-AS1 in human cancer. Clin Transl Oncol. ISSN 1699-048x

(2021) Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer. Breast Dis. pp. 51-62. ISSN 0888-6008

(2021) Tribbles homolog 2 (Trib2), a pseudo serine/threonine kinase in tumorigenesis and stem cell fate decisions. Cell Communication and Signaling.

(2021) An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy. Front Immunol. p. 805695. ISSN 1664-3224